Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis

BACKGROUND: Paracrine signaling between hepatic stellate cells (HSC) and liver endothelial cells (LEC) modulates fibrogenesis, angiogenesis, and portal hypertension. However, mechanisms regulating these processes are not fully defined. Sorafenib is a receptor tyrosine kinase inhibitor that blocks gr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Thabut, Dominique, Routray, Chittaranjan, Lomberk, Gwen, Shergill, Uday, Glaser, Kevin, Huebert, Robert, Patel, Leena, Masyuk, Tetyana, Blechacz, Boris, Vercnocke, Andrew, Ritman, Erik, Ehman, Richard, Urrutia, Raul, Shah, Vijay
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3145033/
https://ncbi.nlm.nih.gov/pubmed/21567441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.24427
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares